Accelrys, a provider of scientific innovation lifecycle management software and solutions, has announced the latest releases of Accelrys Insight and Accelrys Insight for Excel
Accelrys, a provider of scientific innovation lifecycle management solutions, has announced the release of Accelrys Notebook 5.0
Accelrys has announced the launch of ScienceCloud, a new SaaS-based information management and collaboration workspace that is used to advance collaborative drug discovery with new integrated applications built on a scalable, cloud-based scientific platform
Accelrys, a provider of scientific lifecycle management solutions, has announced the release of the Accelrys Materials Studio 7.0, a modelling and simulation environment for chemists, polymer scientists and other materials scientists
Accelrys has released the latest version of its unified biology assay and study management software suite, consisting of BioRails DM 4.5, BioRails PTO 4.5 and Morphit 3.0
Accelrys has announced the availability of an extensive set of advanced predictive sciences applications and services
Accelrys Insight and Accelrys Insight for Excel have been released, completing the roll-out of the company's next-generation cheminformatics suite and providing an interactive, collaborative environment for rapid and effective decision-making in drug discovery
Accelrys, a provider of scientific innovation lifecycle management (SILM) software, has launched its Enterprise Platform 9.0, an open, scientifically aware platform delivering breakthrough capabilities for managing big data and externalised research collaboration networks
Accelrys, a provider of scientific innovation lifecycle management software, has launched its Experiment Knowledge Base
Accelrys has launched its Externalized Collaboration Suite, a software solution designed specifically to address the needs of life sciences organisations engaged in externalised network research
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.
Cloud research tools provide a platform for new avenues of scientific research by providing fast access to bare-metal resources.
New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.
Tate Cantrell, CTO, Verne Global, comments on the cost of the AI computing revolution
European researchers are working on a new programming environment for exascale computing that aims to make using these systems more efficient and programmers more productive.
